Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation

Abstract

The members of the Src kinase family are expressed in a wide variety of tissues, but some of them such as Blk, Hck, Fgr, Lck and Lyn are found primarily in hematopoietic cells. In the present study, we have undertaken experiments to test whether Src kinase cleavage and relocation is a general mechanism during induction of apoptosis. Our results indicate that Fyn and Lyn are efficiently cleaved in their unique region in hematopoietic cells undergoing apoptosis. Fyn cleavage occurred in Fas-stimulated Jurkat T cells but Fyn and Lyn were also processed in the SKW6.4 B cell line. Inhibition of caspases by Z-VAD-fmk or Ac-DEVD-CHO totally prevented Fyn and Lyn cleavage in both intact cells and in vitro. Fyn and Lyn but not Lck, Src and Hck were processed in vitro by human recombinant caspase 3 and by cellular extracts prepared from Fas-stimulated cells. Single mutation of Asp 19 or Asp 18 in the unique N-terminal domains of Fyn and Lyn respectively abolished their cleavage and relocation into the cytoplasm of apoptotic cells. When immunoprecipitated from COS cells N-terminal deleted Src kinases exhibited increased enzymatic kinase activity toward enolase. Thus, cleavage of Fyn and Lyn during induction of apoptosis represents a new mechanism for the regulation of Src kinases that may have important functional and physiological consequences.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Appleby MW, Gross JA, Cooke MP, Levin SD, Qian X, Perlmutter RM . 1992 Cell 70: 751–763

  • Atkinson EA, Ostergaard H, Kane K, Pinkoski MJ, Caputo A, Olszowy MW, Bleackley RC . 1996 J. Biol. Chem. 271: 5968–5971

  • Bertolotto C, Maulon L, Filippa N, Baier G, Auberger P . 2000a J. Biol. Chem. 275: 37246–37250

  • Bertolotto C, Ricci JE, Luciano F, Mari B, Chambard JC, Auberger P . 2000b J. Biol. Chem. 275: 12941–12947

  • Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC . 1998 Science 282: 1318–1321

  • Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA . 1997 Immunity 7: 69–81

  • Corey SJ, Anderson SM . 1999 Blood 93: 1–14

  • Denny MF, Patai B, Straus DB . 2000 Mol. Cell. Biol. 20: 1426–1435

  • Dymecki SM, Niederhuber JE, Desiderio SV . 1990 Science 247: 332–336

  • Gervais FG, Veillette A . 1995 Mol. Cell. Biol. 15: 2393–2401

  • Golden A, Nemeth SP, Brugge JS . 1986 Proc. Natl. Acad. Sci. USA 83: 852–856

  • Hengartner MO . 2000 Nature 407: 770–776

  • Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, Peyron JF . 1996 Cell 86: 787–798

  • Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N . 2000 Nat. Med. 6: 41–48

  • Johnson TM, Williamson NA, Scholz G, Jaworowski A, Wettenhall RE, Dunn AR, Cheng HC . 2000 J. Biol. Chem. 275: 33353–33364

  • Katsuta H, Tsuji S, Niho Y, Kurosaki T, Kitamura D . 1998 J. Immunol. 160: 1547–1551

  • Kawakami Y, Furue M, Kawakami T . 1989 Oncogene 4: 389–391

  • Krueger J, Zhao YH, Murphy D, Sudol M . 1991 Oncogene 6: 933–940

  • Mari B, Checler F, Ponzio G, Peyron JF, Manie S, Farahifar D, Rossi B, Auberger P . 1992 EMBO J. 11: 3875–3885

  • Maruo A, Oishi I, Sada K, Nomi M, Kurosaki T, Minami Y, Yamamura H . 1999 Int. Immunol. 11: 1371–1380

  • Nicholson DW, Thornberry NA . 1997 Trends Biochem. Sci. 22: 299–306

  • Nunez G, Benedict MA, Hu Y, Inohara N . 1998 Oncogene 17: 3237–3245

  • Pleiman CM, Clark MR, Gauen LK, Winitz S, Coggeshall KM, Johnson GL, Shaw AS, Cambier JC . 1993 Mol. Cell. Biol. 13: 5877–5887

  • Qin S, Minami Y, Kurosaki T, Yamamura H . 1997 J. Biol. Chem. 272: 17994–17999

  • Ricci JE, Maulon L, Luciano F, Guerin S, Livolsi A, Mari B, Breittmayer JP, Peyron JF, Auberger P . 1999 Oncogene 18: 3963–3969

  • Ricci JE, Lang V, Luciano F, Belhacene N, Giordanengo V, Michel F, Bismuth G, Auberger P . 2001 FASEB J. in press

  • Rudd CE, Barber EK, Burgess KE, Hahn JY, Odysseos AD, Sy MS, Schlossman SF . 1991 Adv. Exp. Med. Biol. 292: 85–96

  • Sarosi GA, Thomas PM, Egerton M, Phillips AF, Kim KW, Bonvini E, Samelson LE . 1992 Int. Immunol. 4: 1211–1217

  • Scaffidi C, Fulda S, Srinivasan A, Friescu C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME . 1998 EMBO J. 17: 1675–1687

  • Schlessinger J . 2000 Cell 100: 293–296

  • Schwartzberg PL . 1998 Oncogene 17: 1463–1468

  • Sefton BM, Taddie JA . 1994 Curr. Opin. Immunol. 6: 372–379

  • Simon HU, Yousefi S, Dibbert B, Hebestreit H, Weber M, Branch DR, Blaser K, Levi-Schaffer F, Anderson GP . 1998 Blood 92: 547–557

  • Slee EA, Harte MT, Kluck RM, Wolf BB, Casiano CA, Newmeyer DD, Wang HG, Reed JC, Nicholson DW, Alnemri ES, Green DR, Martin SJ . 1999 J. Cell. Biol. 144: 281–292

  • Sudol M, Greulich H, Newman L, Sarkar A, Sukegawa J, Yamamoto T . 1993 Oncogene 8: 823–831

  • Thornberry NA, Lazebnik Y . 1998 Science 281: 1312–1316

  • Veillette A, Bookman MA, Horak EM, Samelson LE, Bolen JB . 1989 Nature 338: 257–259

  • Wang J, Koizumi T, Watanabe T . 1996 J. Exp. Med. 184: 831–838

  • Widmann C, Gibson S, Johnson GL . 1998 J. Biol. Chem. 273: 7141–7147

  • Willman CL, Stewart CC, Longacre TL, Head DR, Habbersett R, Ziegler SF, Perlmutter RM . 1991 Blood 77: 726–734

  • Wolf BB, Green DR . 1999 J. Biol. Chem. 274: 20049–20052

  • Xu W, Doshi A, Lei M, Eck MJ, Harrison SC . 1999 Mol. Cell. 3: 629–638

  • Yamanashi Y, Mori S, Yoshida M, Kishimoto T, Inoue K, Yamamoto T, Toyoshima K . 1989 Proc. Natl. Acad. Sci. USA 86: 6538–6542

  • Yi TL, Bolen JB, Ihle JN . 1991 Mol. Cell. Biol. 11: 2391–2398

  • Yurchak LK, Sefton BM . 1995 Mol. Cell. Biol. 15: 6914–6922

  • Zhao YH, Baker H, Walaas SI, Sudol M . 1991 Oncogene 6: 1725–1733

Download references

Acknowledgements

This work was supported by INSERM and the Ligue Nationale Contre le Cancer (Equipe labellisée LNC). The authors thank Bernard Mari for critical reading of the manuscript. We are indebted to Dr Sarah Courtneidge for providing p59Fyn and p60Src cDNAs, to Dr Victor Tybulewicz for the kind gift of p56Lyn cDNA and to Dr Yves Colette and Pr Daniel Olive for Hck cDNA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick Auberger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luciano, F., Ricci, JE. & Auberger, P. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation. Oncogene 20, 4935–4941 (2001). https://doi.org/10.1038/sj.onc.1204661

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204661

Keywords

This article is cited by

Search

Quick links